Antibiotic Prophylaxis in Lung-Transplant Recipients

NCT06760143 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 90

Last updated 2025-01-10

No results posted yet for this study

Summary

Retrospective, monocentric observational pharmacological cohort study including all adult patients who underwent lung transplantation at IRCCS Azienda Ospedaliero-Universitaria di Bologna from 1st January 2002 to 31st August 2023.

Conditions

  • Lung-transplant Recipients
  • Antibiotic Prophylaxis

Sponsors & Collaborators

  • IRCCS Azienda Ospedaliero-Universitaria di Bologna

    lead OTHER

Principal Investigators

  • Renato Pascale, MD · IRCCS Azienda Ospedaliero-Universitaria di Bologna

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-12
Primary Completion
2024-10-31
Completion
2024-10-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06760143 on ClinicalTrials.gov